23.07.07
Works on tests of a medication of the open joint-stock company "FiBr-Med" have begunThe given tests spent in the Blohin Russian oncological science centre of Russian Academy of Medical Science and the Kovalenko Russian scientific research institute of experimental veterinary science, will allow to receive a number of the additional documents confirming antileukemic, antineoplastic and antibacterial activity of a preparation.
|